Medicine & Life Sciences
Inflammatory Bowel Diseases
100%
Crohn Disease
79%
Pouchitis
53%
vedolizumab
40%
Restorative Proctocolectomy
39%
Biological Therapy
19%
Microbiota
19%
Sclerosing Cholangitis
18%
Colonic Pouches
14%
Ustekinumab
13%
Colitis
13%
Therapeutics
12%
Immunologic Factors
12%
Colon
10%
Tumor Necrosis Factor-alpha
10%
Adalimumab
10%
Endoscopy
9%
Postoperative Complications
9%
Hyperbaric Oxygenation
9%
Anti-Bacterial Agents
8%
Inflammation
8%
Colectomy
7%
Infliximab
7%
Biological Products
7%
Steroids
6%
Mucous Membrane
6%
Odds Ratio
6%
Safety
5%
Surgical Wound Infection
5%
Colonoscopy
5%
Multicenter Studies
5%
Bariatric Surgery
5%
Pharmaceutical Preparations
5%
Gastrointestinal Microbiome
5%
Ileum
5%
Hospitalization
5%
Quality of Life
5%
Mesalamine
5%